Central venous access devices for paediatric patients with haemophilia: a single-institution experience

R Titapiwatanakun1, C Moir, R K Pruthi

  • 1Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, Minnesota, USA. rodriguez.vilmarie@mayo.edu

Insights

Central venous access devices (CVADs) enable home infusions for children with bleeding disorders. Infections are the main complication, particularly in patients with Factor VIII inhibitors, though overall rates remain low with proper technique.

Area of Science:

  • Pediatric Hematology
  • Vascular Access Devices
  • Bleeding Disorders Management

Background:

  • Central venous access devices (CVADs) are crucial for home-based factor concentrate infusions in children with bleeding disorders.
  • These infusions support long-term prophylaxis and immune tolerance therapy.

Purpose of the Study:

  • To review the outcomes and complications associated with CVAD use in pediatric patients with bleeding disorders.
  • To evaluate the safety and efficacy of CVADs in this specific patient population.

Main Methods:

  • Retrospective review of 37 CVADs placed in 18 pediatric patients at the Mayo Clinic Comprehensive Hemophilia Center.
  • Data collected included patient diagnoses (hemophilia A, von Willebrand disease, hemophilia B), CVAD dwell time, and complications.

Main Results:

  • A total of 45,952 CVAD days were recorded, with a median dwell time of 1361 days per device.
  • Ten CVAD-related infections occurred (0.22 per 1000 days), with a higher incidence in patients with Factor VIII inhibitors.
  • No clinically apparent thrombosis was observed; infection was the most common complication.

Conclusions:

  • CVADs are effective for home-based therapy in pediatric bleeding disorders, but infection risk is increased in patients with inhibitors.
  • Strict adherence to aseptic technique is crucial for minimizing infection rates.
  • The study highlights the safety of CVADs when managed with appropriate protocols, despite the absence of routine thrombosis screening.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...